Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Digital PCR-based dynamic monitoring of JAK2V617F burden: A decade-long study unravels its prognostic value in MPN treatment response

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHao CaiLJLi JMDMinghui Duan

Discussion

Loading...

Member takes

Overview

Dynamic monitoring of JAK2V617F burden reveals treatment efficacy in polycythemia vera, indicating personalized approaches through molecular response assessment.

Key Points

  • Digital PCR quantifies JAK2V617F variants, enhancing response prediction and treatment efficacy in MPNs.
  • Patients with polycythemia vera show 71% molecular response to interferon-alpha therapy, compared to 43% in essential thrombocythemia.
  • This cohort study assesses mutation burdens and their correlation with molecular response across various MPN subtypes.
  • Early molecular response kinetics serve as useful indicators for therapeutic assessment and prognosis in precision medicine.

Cite This Study

Cai et al. (2025) studied this question.

synapsesocial.com/papers/69362f694fa91c937236df79https://doi.org/10.1182/blood-2025-5597
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-frequency monitoring of clonal dynamics in MPN using saliva and peripheral blood during interferon therapy2025 · 1 citations
  2. 2Transcriptomic signatures associated with deep molecular response to ropeginterferon alfa-2b in polycythemia vera2025
  3. 3Longitudinal genomic shifts associated with disease transformation in patients with polycythemia vera (PV) enrolled in REVEAL2025
  4. 4Functional annotation of MPN clones reveals mutation-specific fitness and fate bias2025
  5. 5Optimized Test Utilization Significantly Increased the Positive Detection Rate for Myeloproliferative Neoplasms2026